Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Hi David- I have a query regarding my mom and MRI with contrast wanted to run by you. She is all in all doing well. She is now in what they call partial remission. Her IGG has come down to
She feels mild pain in her back that oscillates all over her back, so not in one specific place, and in her left shoulder where we know she has a lesion as it came up on a past MRI. The pain comes and goes, but she says it isn’t very strong.
In 2023, right after she was first diagnosed in November 2022, she would get MRI’s every 3 months with contrast as we thought this was the only way to take a look at her lesions, and she was having all sorts of pain etc.
Back then we didn’t know about the potential side effects of gadolinium. We’re unsure if she should get MRI’s without contrast and wait until next year and then get them done with contrast. The reason she would potentially want to get them done now is to monitor these pains she has and to keep an eye on any potential new lesions and to keep an eye on old ones. Also, at the end of the year she has met the deductible with her insurance so we won’t have to pay out of pocket for her to get these now so we figured it would be good for her to get them.
I am questioning if it is ever beneficial to get an MRI with contrast, with the gadolinium? And I believe last time we spoke you said that gadolinium actually enhances/ can make myeloma worse?
Have you heard of Clariscan, as an alternative to gadolinium?
Finally, we have heard that taking a dosage of zinc can help combat the side effects of gadolinium, but I am unsure if this is proven. Have you heard of this? Thank you so much as always David,
What are some typical contrast agents used with MRI imaging?
Hi Julia-
“Bone marrow infiltration by myeloma cells and osteolytic bone lesions are the major features of Multiple Myeloma. Magnetic Resonance Imaging (MRI) has been used in MM not only to image bone marrow (BM) and to identify lytic bone disease but to also evaluate therapeutic response and prognosis.
Gadolinium (Gd)-based contrast agents are frequently used to enhance MRI resolution. We evaluated effect of the most common Gd-containing agent, Omniscan, on myeloma cells.
We observed that Omniscan induced both time and dose dependent MM cell growth in vitro (8-20 fold increase relative to control). Importantly, the presence of BMSC enhanced the effect of Omniscan on growth of both MM cell lines and primary MM cells.
However, Omniscan was not able to overcome cytotoxic effects of conventional and novel agents in MM. This growth promoting effects were not observed on normal BM stromal cells. Evaluating the molecular mechanism of action of Omniscan on MM cells, we observed time dependent ERK1/2 phosphorylation as well as reversal of growth promoting effects of Omniscan by specific inhibition of ERK signaling; however, Omniscan had no effect on STAT3 and AKT signaling pathways…”
“Researchers at Massachusetts General Hospital (MGH) have taken a key step forward in developing a new, possibly safer contrast agent for use in magnetic resonance imaging (MRI) exams. Contrast enhanced MRI is a widely used diagnostic tool with over 30 million procedures performed annually. Currently, gadolinium-based contrast agents (GBCAs) are used for this purpose, but recently concerns have been raised about the long-term safety of the gadolinium metal ion…”
MRI with contrast MRI with contrast